Virtus Investment Advisers’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$284K Buy
4,303
+56
+1% +$3.56K 0.08% 291
2025
Q4
$270K Buy
4,247
+819
+24% +$50.9K 0.07% 293
2025
Q3
$188K Buy
3,428
+596
+21% +$24.6K 0.05% 260
2025
Q2
$93.6K Sell
2,832
-438
-13% -$15.2K 0.03% 360
2025
Q1
$131K Buy
+3,270
New +$150K 0.04% 374
2024
Q1
Sell
-4,718
Closed -$394K 355
2023
Q4
$394K Sell
4,718
-3,946
-46% -$143K 0.3% 107
2023
Q3
$255K Buy
8,664
+720
+9% +$24K 0.17% 146
2023
Q2
$259K Sell
7,944
-4,870
-38% -$180K 0.18% 157
2023
Q1
$451K Sell
12,814
-1,767
-12% -$72.1K 0.32% 101
2022
Q4
$668K Hold
14,581
0.45% 60
2022
Q3
$706K Buy
+14,581
New +$702K 0.32% 50

Other funds holding CYTK